67/100B152.200
USD
3.65
(2.46%)
Pre Open·151.190USD-1.010(-0.66%)
Last updated: · Delayed 15 min
Atlassian stock forecast 2027–2029What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Atlassian is 219.06, 43.9% above the current price of 152.20. Their targets range from 170.00 to 280.00.
Of the 24 firms that rated Atlassian in the past 12 months, 20 rate it buy or strong buy, 4 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
12-month price target
219.06 USD
+43.93%
Analysts' 1-year price targets range from 170.00 to 280.00, with an average of 219.06.
Past year
1-year forecast
Strong sellStrong buy
Strong buy
24 ratings
| Buy | 20 | |
| Hold | 4 | |
| Sell | 0 |
12-month price target
| Highest target | 280.00 |
| Average target | 219.06 |
| Lowest target | 170.00 |
| Current price | 152.20 |
Atlassian price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Atlassian price target and rating?
See how analysts moved their price target
How analysts rate Atlassian, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
20 of 24 firms rate it buy now, against 19 of 24 in December 2025.
Buy Hold Sell
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Atlassian analyst upgrades, downgrades and price targets
The latest rating change came on 17 April 2026, when BWG Global downgraded Atlassian from Positive to Mixed. The most recent new target came from Piper Sandler on 6 November 2026: 190.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 6 Nov 2026 | Piper Sandler Rob Owens | Reiterated · Overweight | 200.00 → 190.00 | -5.0% | 154.54 |
| 6 Nov 2026 | Guggenheim Howard Ma | — | 165.00 → 280.00 | +69.7% | 183.29 |
| 30 Oct 2026 | BMO Capital Keith Bachman | — | 175.00 → 225.00 | +28.6% | 204.10 |
| 23 Oct 2026 | UBS | — | 280.00 → 252.00 | -10.0% | 222.29 |
| 20 Oct 2026 | BTIG Allan Verkhovski | Reiterated · Buy | 230.00 → 260.00 | +13.0% | 214.75 |
| 19 Oct 2026 | UBS | — | 160.00 → 280.00 | +75.0% | 210.65 |
| 19 Oct 2026 | KeyBanc Jason Celino | Reiterated · Overweight | 185.00 → 235.00 | +27.0% | 208.68 |
| 14 Oct 2026 | Wells Fargo Ryan MacWilliams | Reiterated · Overweight | 180.00 → 230.00 | +27.8% | 208.04 |
| 13 Oct 2026 | Barclays | Reiterated · Overweight | 172.00 → 222.00 | +29.1% | 207.75 |
| 12 Oct 2026 | RBC Capital | Reiterated · Outperform | 215.00 → 235.00 | +9.3% | 207.22 |
| 28 Sept 2026 | Robert W. Baird | — | 200.00 → 245.00 | +22.5% | 187.74 |
| 21 Sept 2026 | Cantor Fitzgerald Thomas Blakey | Reiterated · Overweight | 126.00 → 220.00 | +74.6% | 192.02 |
| 14 Sept 2026 | Mizuho Securities | — | 145.00 → 215.00 | +48.3% | 179.70 |
| 3 Sept 2026 | BTIG | Reiterated · Buy | 180.00 → 230.00 | +27.8% | 186.44 |
| 25 Aug 2026 | RBC Capital | — | 215.00 | — | 166.49 |
| 20 Aug 2026 | Truist Financial | Reiterated · Buy | 160.00 → 185.00 | +15.6% | 174.23 |
| 10 Aug 2026 | FBN Securities Shebly Seyrafi | — | 170.00 | — | 151.87 |
| 10 Aug 2026 | Barclays | Reiterated · Overweight | 112.00 → 172.00 | +53.6% | 149.07 |
| 7 Aug 2026 | Truist Financial | Reiterated · Buy | 100.00 → 160.00 | +60.0% | 144.14 |
| 7 Aug 2026 | Raymond James | — | 130.00 → 180.00 | +38.5% | 143.64 |
| 7 Aug 2026 | Morgan Stanley | Reiterated · Overweight | 120.00 → 180.00 | +50.0% | 144.39 |
| 7 Aug 2026 | UBS | Reiterated · Neutral | 105.00 → 160.00 | +52.4% | 144.10 |
| 7 Aug 2026 | Robert W. Baird Rob Oliver | — | 120.00 → 200.00 | +66.7% | 143.95 |
| 7 Aug 2026 | BMO Capital | — | 95.00 → 175.00 | +84.2% | 150.04 |
| 7 Aug 2026 | Guggenheim | Reiterated · Buy | 115.00 → 165.00 | +43.5% | 110.17 |
| 7 Aug 2026 | Wells Fargo Ryan MacWilliams | Reiterated · Overweight | 155.00 → 180.00 | +16.1% | 110.17 |
| 7 Aug 2026 | KeyBanc | Reiterated · Overweight | 115.00 → 185.00 | +60.9% | 110.17 |
| 7 Aug 2026 | BTIG Allan Verkhovski | Reiterated · Buy | 120.00 → 180.00 | +50.0% | 110.17 |
| 7 Aug 2026 | Jefferies Brent Thill | — | 150.00 → 200.00 | +33.3% | 110.17 |
| 3 Aug 2026 | Cantor Fitzgerald Thomas Blakey | — | 107.00 → 126.00 | +17.8% | 104.05 |
| 8 Jul 2026 | KeyBanc | Reiterated · Overweight | 170.00 → 115.00 | -32.4% | 88.39 |
| 25 Jun 2026 | BMO Capital | Reiterated · Outperform | 130.00 → 95.00 | -26.9% | 77.34 |
| 11 May 2026 | Oppenheimer | Reiterated · Outperform | 100.00 → 110.00 | +10.0% | 91.60 |
| 7 May 2026 | Barclays | Reiterated · Overweight | 106.00 → 112.00 | +5.7% | 88.80 |
| 1 May 2026 | Robert W. Baird Rob Oliver | — | 140.00 → 120.00 | -14.3% | 83.73 |
| 1 May 2026 | Bernstein Peter Weed | — | 290.00 → 295.00 | +1.7% | 83.83 |
| 1 May 2026 | Truist Financial | Reiterated · Buy | 90.00 → 100.00 | +11.1% | 84.71 |
| 1 May 2026 | Cantor Fitzgerald Thomas Blakey | Reiterated · Overweight | 98.00 → 107.00 | +9.2% | 85.33 |
| 1 May 2026 | BTIG | Reiterated · Buy | 140.00 → 120.00 | -14.3% | 68.59 |
| 1 May 2026 | Raymond James | — | 250.00 → 130.00 | -48.0% | 68.59 |
| 1 May 2026 | Barclays | Reiterated · Overweight | 100.00 → 106.00 | +6.0% | 68.59 |
| 27 Apr 2026 | Cantor Fitzgerald Thomas Blakey | — | 240.00 → 98.00 | -59.2% | 71.55 |
| 20 Apr 2026 | Barclays | — | 165.00 → 100.00 | -39.4% | 70.31 |
| 17 Apr 2026 | Oppenheimer | Reiterated · Outperform | 150.00 → 100.00 | -33.3% | 68.73 |
| 17 Apr 2026 | BWG Global | Downgraded · Positive → Mixed | — | — | — |
| 16 Apr 2026 | Morgan Stanley Keith Weiss | Reiterated · Overweight | 290.00 → 120.00 | -58.6% | 66.00 |
| 15 Apr 2026 | Truist Financial | — | 210.00 → 90.00 | -57.1% | 64.41 |
| 15 Apr 2026 | Canaccord Genuity | Reiterated · Buy | 185.00 → 150.00 | -18.9% | 59.71 |
| 14 Apr 2026 | Mizuho Securities | Reiterated · Outperform | 185.00 → 145.00 | -21.6% | 61.30 |
| 9 Apr 2026 | Guggenheim | — | 115.00 | — | 58.96 |
Atlassian EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Revenue
ReportedEstimate
EPS
ReportedEstimate
Does Atlassian beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 21.1% off the result, either way, and their revenue estimate 3.3%, over the last 12 quarters.
- EPS beats
- 42 / 44
- Revenue beats
- 41 / 44
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +21.1%
- Since
- February 2016
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q1 FY2027 | 5 Nov 2026 | 1.39 | 1.65 | +18.7% | 1.71B | 1.77B | +3.4% |
| Q4 FY2026 | 6 Aug 2026 | 1.50 | 1.87 | +24.7% | 1.66B | 1.77B | +6.2% |
| Q3 FY2026 | 30 Apr 2026 | 1.33 | 1.75 | +31.6% | 1.70B | 1.79B | +5.4% |
| Q2 FY2026 | 5 Feb 2026 | 1.15 | 1.22 | +6.1% | 1.56B | 1.59B | +1.9% |
| Q1 FY2026 | 30 Oct 2025 | 0.84 | 1.04 | +24.0% | 1.40B | 1.43B | +2.2% |
| Q4 FY2025 | 7 Aug 2025 | 0.83 | 0.98 | +17.5% | 1.36B | 1.38B | +2.1% |
| Q3 FY2025 | 1 May 2025 | 0.90 | 0.97 | +7.4% | 1.35B | 1.36B | +0.3% |
| Q2 FY2025 | 30 Jan 2025 | 0.75 | 0.96 | +27.3% | 1.24B | 1.29B | +3.8% |
| Q1 FY2025 | 31 Oct 2024 | 0.64 | 0.77 | +20.7% | 1.16B | 1.19B | +2.8% |
| Q4 FY2024 | 1 Aug 2024 | 0.58 | 0.66 | +13.6% | 1.13B | 1.13B | +0.1% |
| Q3 FY2024 | 25 Apr 2024 | 0.62 | 0.89 | +43.5% | 1.10B | 1.19B | +8.3% |
| Q2 FY2024 | 1 Feb 2024 | 0.62 | 0.73 | +17.7% | 1.02B | 1.06B | +3.6% |
Atlassian stock price 2027–2029: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
There are no price scenarios for Atlassian: its P/E has been above 60, or from losses, too often in the last five years to price its earnings at, and similar companies' P/Es put its value too far from its price to stand in. The earnings analysts expect are in the estimates above.
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 376.23 | 747.73561Price 376.23935 | +98.7% | |
| 152.620 | 297.58169Price 152.62471 | +95.0% | |
| 158.390 | 305.52158Price 158.39396 | +92.9% | |
| 241.410 | 464.73205Price 241.41627 | +92.5% | |
| 156.930 | 300.15225Price 156.93375 | +91.3% | |
| 37.540 | 71.4258Price 37.54193 | +90.3% | |
| 217.080 | 405.47304Price 217.08507 | +86.8% |
Furthest below the fair value on each stock's page, updated every day.